Fidelity Investments’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,000
| Closed | -$3K | – | 5766 |
|
|
2021
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 3976 |
|
|
2021
Q3 | $4K | Buy |
1,000
+966
| +2,841% | +$3.64K | ﹤0.01% | 3885 |
|
|
2021
Q2 | $0 | Buy |
+34
| New | +$120 | ﹤0.01% | 5246 |
|
|
2018
Q4 | – | Sell |
-118
| Closed | – | – | 4507 |
|
|
2018
Q3 | $0 | Buy |
+118
| New | +$331 | ﹤0.01% | 3944 |
|
|
2016
Q2 | – | Sell |
-511,479
| Closed | -$1.65M | – | 2775 |
|
|
2016
Q1 | $1.65M | Sell |
511,479
-2,191,873
| -81% | -$8.1M | ﹤0.01% | 2421 |
|
|
2015
Q4 | $12.9M | Buy |
2,703,352
+2,090,896
| +341% | +$11.9M | ﹤0.01% | 1879 |
|
|
2015
Q3 | $3.4M | Sell |
612,456
-41,843
| -6% | -$309K | ﹤0.01% | 2283 |
|
|
2015
Q2 | $5.21M | Sell |
654,299
-700
| -0.1% | -$6.01K | ﹤0.01% | 2228 |
|
|
2015
Q1 | $6.88M | Sell |
654,999
-1,450,500
| -69% | -$19.8M | ﹤0.01% | 2134 |
|
|
2014
Q4 | $25.3M | Sell |
2,105,499
-274,600
| -12% | -$4.17M | ﹤0.01% | 1633 |
|
|
2014
Q3 | $40.7M | Sell |
2,380,099
-302,884
| -11% | -$4.4M | 0.01% | 1387 |
|
|
2014
Q2 | $32.4M | Sell |
2,682,983
-362,600
| -12% | -$3.44M | ﹤0.01% | 1565 |
|
|
2014
Q1 | $25.7M | Buy |
3,045,583
+117,952
| +4% | +$952K | ﹤0.01% | 1657 |
|
|
2013
Q4 | $17.2M | Sell |
2,927,631
-2,761,669
| -49% | -$14.2M | ﹤0.01% | 1771 |
|
|
2013
Q3 | $30.9M | Buy |
5,689,300
+503,000
| +10% | +$2.42M | ﹤0.01% | 1507 |
|
|
2013
Q2 | $21.1M | Buy |
+5,186,300
| New | +$24.3M | ﹤0.01% | 1646 |
|
Other funds holding BDSI
Fidelity Investments's BDSI Position: Q1 2022 in Review
Fidelity Investments sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 1,000 shares — an estimated $3K sold.
Fidelity Investments first reported a position in BDSI in Q2 2013 and held it in 16 quarters. The position peaked at $40.7M in Q3 2014. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Fidelity Investments reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Fidelity Investments sold 1,000 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $3K.
- Fidelity Investments first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 16 quarters.
- Fidelity Investments's BioDelivery Sciences International, Inc. position peaked at $40.7M in Q3 2014.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Fidelity Investments's 13F filing for Q1 2022, filed 13 May 2022.